# The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency

Study · id `cardio:ct-nct01598337` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01598337](<https://clinicaltrials.gov/study/NCT01598337>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01598337

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT01598337. Randomized; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT01598337, source copy `cardio:ctgov-nct01598337-2012-05-15`, retrieved 2026-10-26)
- Start date: 2011-04 (registry gives no type) (ClinicalTrials.gov record NCT01598337, source copy `cardio:ctgov-nct01598337-2012-05-15`, retrieved 2026-10-26)
- Primary completion: 2013-12 (anticipated) (ClinicalTrials.gov record NCT01598337, source copy `cardio:ctgov-nct01598337-2012-05-15`, retrieved 2026-10-26)
- Completion: Not reported
- Countries: Saudi Arabia (ClinicalTrials.gov record NCT01598337, source copy `cardio:ctgov-nct01598337-2012-05-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01598337-2012-05-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency
- Condition: Coronary Artery Disease
- Intervention (Drug): Aspirin
- Intervention (Drug): Tirofiban
- Intervention (Drug): Clopidogrel
- Intervention (Drug): Prasugrel
- Lead sponsor: Prince Sultan Cardiac Center, Adult Cardiology Department.
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention name matches this record: Prasugrel (`cardio:prasugrel`)

## Provenance

Content hash: 0d7e365954395e7acd0e2c5879d1013c1de3f69bb38bc75185f6d4ada370c812
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
